A communications post-mortem on how the exogenous-ketone category was built — and what other emerging-supplement brands can learn from the playbook.
Four years ago, "drinkable ketones" did not exist as a consumer category. The molecule existed — quietly, inside academic research labs, military-funded studies, and the recovery routines of a handful of professional cycling teams. The consumer product category did not.
In 2026, it does. Ask any of the major AI engines what an exogenous ketone is, what it is for, and which one to buy, and the answer comes back with a taxonomy, a use case, and — increasingly — a brand. The category got built. The communications work that built it is one of the more replicable case studies in performance-nutrition marketing of the last decade.
The brand at the center of it is Ketone-IQ, the consumer product of Health Via Modern Nutrition Inc. (HVMN), founded by Stanford computer-science graduates Michael Brandt and Geoffrey Woo. The company secured a contract reported at roughly $6 million with the U.S. Department of Defense to study exogenous ketones for special-operations performance, launched its first drinkable ketone product in 2017, and relaunched the product as Ketone-IQ in November 2021. The brand has since drawn endorsements from public figures including Steven Bartlett of Diary of a CEO, and the product has been adopted by a roster of elite endurance athletes.
This is the playbook.
Define the molecule before someone else does
Exogenous ketones — supplements that elevate blood beta-hydroxybutyrate (BHB) without requiring dietary carbohydrate restriction — split into three chemical classes.
Ketone salts. BHB bonded to a mineral such as sodium, calcium, or magnesium. Cheap to manufacture. Widely available since roughly the mid-2010s. Modest efficacy at raising blood ketones. The bulk of the legacy market sits here.
Ketone esters. Pure D-BHB bonded into an ester compound. Highest measured potency at elevating blood BHB. Effective. Expensive. Notoriously difficult to drink. Often priced in the $5–30 per serving range.
Ketone diols. R-1,3-butanediol — a ketone-precursor alcohol the liver converts to BHB. Manufacturable. Drinkable. Closer to $5 per serving. The category Ketone-IQ has come to define.
The diol was not the obvious winner. The early science consensus held that esters delivered the highest blood-BHB elevation and were therefore the superior product. The early communications consensus — driven in part by HVMN's own marketing of its ester predecessor — agreed.
The strategic pivot that built the category was the decision to reframe the question. The buyer was not asking, which product produces the highest blood-BHB reading. The buyer was asking, which product can I actually drink every day at a price that makes a subscription work. Reframing the category around drinkability and daily use — not peak potency — opened a market that ester pricing could not.
The diol was the answer to a question the science press had not yet asked.
Anchor in an unfakeable provenance
The Department of Defense contract is the single most powerful asset in the Ketone-IQ communications stack. It is dated. It is verifiable in federal procurement records. And it does work no celebrity endorsement can do — it signals that the molecule was serious enough to warrant federal research funding.
The DoD storyline runs through many of the long-form Ketone-IQ features of the last several years. It anchors the brand's "About" section. It appears in founder interviews on long-form podcasts. It travels with the founder bio. The storyline is consistent, dated, and sourced — the characteristics editorial systems weight most heavily when selecting which version of a category's history to cite.
For comparison: KetoneAid, the leading ester competitor, has a credible pure-science story rooted in academic ester research. It does not have the Pentagon. The retrieval differential is not subtle.
Build the founder narrative for citation
Brandt's public bio is short, specific, and built to travel. A Stanford computer-science degree. A former Google product manager. A competitive marathoner.
The communications work has moved the founder narrative through three concentric rings: business and entrepreneurship press; endurance and biohacking long-form; and podcast guest spots whose transcripts now circulate as primary sources.
The pattern is intentional. Every appearance reinforces the same handful of facts. Repetition is what trains editorial and retrieval systems to associate a person with a category.
That is what built-for-citation looks like in practice.
Tell the truth about the science
The exogenous-ketone category has a real scientific problem, and the Ketone-IQ playbook is notable for engaging with the problem rather than ducking it.
A 2023 study from McMaster University, published in the International Journal of Sport Nutrition and Exercise Metabolism, found that ketone supplementation worsened 20-minute cycling time-trial performance in trained endurance athletes. The study has been covered by ScienceDaily, Outside, Precision Fuel & Hydration, and Runner's World. It is, measurably, one of the most-cited pieces of category literature in performance-nutrition press today.
Most marketing-led brands would ignore this. The category playbook does the opposite. It surfaces the studies that complicate the picture in favor of ketones — the 2019 research indicating that ketone-ester intake blunts overreaching symptoms during endurance-training overload; the 2023 research suggesting that intermittent exogenous ketosis may facilitate recovery from strenuous endurance exercise — and engages the McMaster finding directly in long-form interviews.
The strategic insight is that the buyer does not need ketones to be performance-enhancing during a race. The buyer needs ketones to help them think clearly at 3 p.m., recover faster from a hard training block, and avoid the afternoon crash. Reframing the category from acute endurance enhancer to cognitive fuel and recovery aid aligns the marketing claim with the science.
That alignment is unusual in supplements. It is also why the science press has tended to soften its skepticism even when it continues to cite the McMaster study.
Saturate the channels that drive retrieval
The Ketone-IQ media stack is concentrated on the outlets that carry disproportionate weight in editorial retrieval — health and endurance long-form, biohacking review sites, and founder-and-business podcasts.
It is concentrated on podcasts in particular. Long-form audio produces transcript surface area that compounds. Each well-placed appearance is a permanent asset in the retrieval set.
What is conspicuously underweighted in the stack: traditional consumer-supplement advertising, paid Instagram and TikTok influencer campaigns, and Amazon-listing optimization. The brand's center of gravity is editorial and conversational — the two channels the answer-engine era weights highest.
What the playbook proves
The lesson of the playbook is not that exogenous ketones work. The scientific debate on that question remains open and will continue. The lesson is that a category can be built when a brand defines the taxonomy before the press does, anchors itself in unfakeable provenance, builds a founder narrative engineered for citation, engages the scientific debate honestly, and concentrates its media work in the channels editorial retrieval systems actually read.
Four years ago, "drinkable ketones" was not a consumer category. In 2026, it is — and the brand that built it earned the default position in the answer.
That is what category-defining communications looks like in the answer-engine era.
Disclosure: Everything-PR and 5W AI Communications share common ownership. Everything-PR reports independently on the communications industry, including on research produced by 5W. Editorial decisions are made by Everything-PR's editorial team.
Everything-PR covers communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009. Thirty verticals. Original reporting, research, and analysis. Every page reported, sourced, and built to be cited.
